• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hum Vaccin Immunother . Influenza vaccination landscape in Italy: A comprehensive study through the OBVIOUS project lens

tetano

Editor, Senior Moderator
Hum Vaccin Immunother


. 2023 Aug;19(2):2252250.
doi: 10.1080/21645515.2023.2252250. Epub 2023 Oct 17. Influenza vaccination landscape in Italy: A comprehensive study through the OBVIOUS project lens

Angelo Capodici[SUP] 1 [/SUP], Marco Montalti[SUP] 1 [/SUP], Giorgia Soldà[SUP] 1 [/SUP], Aurelia Salussolia[SUP] 1 [/SUP], Giusy La Fauci[SUP] 1 [/SUP], Zeno Di Valerio[SUP] 1 [/SUP], Francesca Scognamiglio[SUP] 1 [/SUP], Maria Pia Fantini[SUP] 1 [/SUP], Anna Odone[SUP] 2 [/SUP], Claudio Costantino[SUP] 3 [/SUP], Heidi J Larson[SUP] 4 [/SUP], Julie Leask[SUP] 5 6 [/SUP], Jacopo Lenzi[SUP] 1 [/SUP], Davide Gori[SUP] 1 [/SUP]; OBVIOUS Board; Observatory on Vaccine Hesitancy in Italy - Online UniBo Surveys



Collaborators, Affiliations
Abstract

Influenza annually claims an estimated 8,000 lives in Italy. Despite no-cost vaccinations for high-risk groups, hesitancy persists. This study aims to pinpoint social and behavioral vaccination determinants, forming strategies to bolster vaccine uptake. From April 11 to May 29, 2022, we surveyed a demographic-stratified sample of 10,000 Italian adults, employing the WHO's Behavioral and Social Drivers of Vaccination (BesD) framework. Of those, 4,613 (46.1%) were eligible for the influenza vaccine and included in the analysis. Roughly a third remained unvaccinated and unwilling. Central Italy showed the highest resistance, with significant percentages of seniors and professionals like teachers, law enforcement, and healthcare workers expressing noncompliance. A lack of awareness of being in a target group correlated significantly with vaccine refusal or delayed acceptance. Other refusal factors included female gender, being aged 45-54, rural residency, absence of higher education, perceived vaccine unsafety, and having vaccine-opposed acquaintances. Thus, addressing these perceptions and enhancing awareness can potentially increase vaccination rates and lessen disease impact.

Keywords: Vaccine; health-policy; hesitancy; influenza; social and behavioral determinants; uptake.

 
Back
Top Bottom